SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 113, Issue 1, 2014, Pages 191-192

Long-term consequences of the right ventricular pacing mania of the 1990s for obstructive hypertrophic cardiomyopathy

(2) Maron, Barry J a Josephson, Mark E b

a MINNEAPOLIS HEART INSTITUTE FOUNDATION (United States)

b HARVARD MEDICAL SCHOOL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DABIGATRAN; DILTIAZEM; DISOPYRAMIDE; PREDNISONE; SOTALOL; VERAPAMIL;

ADULT; CARDIOVERSION; CASE REPORT; DUAL CHAMBER PACEMAKER; DYSPNEA; ECHOCARDIOGRAPHY; EDITORIAL; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PACING; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LUNG ARTERY PRESSURE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RIGHT VENTRICULAR PACING MANIA; THORAX PAIN; TISSUE DOPPLER IMAGING; TRICUSPID VALVE REGURGITATION;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MIDDLE AGED; TIME FACTORS; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84890430290 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2013.09.041 Document Type: Editorial

Times cited : (4)

References (12)

1
- 0026652911
- Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy
- L. Fananapazir, R.O. Cannon III, D. Tripodi, and J.A. Panza Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy Circulation 85 1992 2149 2161
- (1992) Circulation , vol.85 , pp. 2149-2161
- Fananapazir, L.¹ Cannon III, R.O.² Tripodi, D.³ Panza, J.A.⁴

2
- 0028650316
- Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
- L. Fananapazir, N.D. Epstein, R.V. Curiel, J.A. Panza, D. Tripodi, and D. McAreavey Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy Circulation 90 1994 2731 2742
- (1994) Circulation , vol.90 , pp. 2731-2742
- Fananapazir, L.¹ Epstein, N.D.² Curiel, R.V.³ Panza, J.A.⁴ Tripodi, D.⁵ McAreavey, D.⁶

3
- 0033002903
- Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing in Cardiomyopathy
- C. Linde, F. Gadler, L. Kappenberger, and L. Rydén Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy Am J Cardiol 83 1999 903 907
- (1999) Am J Cardiol , vol.83 , pp. 903-907
- Linde, C.¹ Gadler, F.² Kappenberger, L.³ Rydén, L.⁴

4
- 8544240103
- Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
- L. Kappenberger, C. Linde, C. Daubert, W. McKenna, E. Meisel, N. Sadoul, L. Chojnowska, L. Guize, D. Gras, X. Jeanrenaud, and L. Rydén Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial Eur Heart J 18 1997 1249 1256
- (1997) Eur Heart J , vol.18 , pp. 1249-1256
- Kappenberger, L.¹ Linde, C.² Daubert, C.³ McKenna, W.⁴ Meisel, E.⁵ Sadoul, N.⁶ Chojnowska, L.⁷ Guize, L.⁸ Gras, D.⁹ Jeanrenaud, X.¹⁰ Rydén, L.¹¹

5
- 0033536029
- Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)
- B.J. Maron, R.A. Nishimura, W.J. McKenna, H. Rakowski, M.E. Josephson, and R.S. Kieval Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY) Circulation 99 1999 2927 2933
- (1999) Circulation , vol.99 , pp. 2927-2933
- Maron, B.J.¹ Nishimura, R.A.² McKenna, W.J.³ Rakowski, H.⁴ Josephson, M.E.⁵ Kieval, R.S.⁶

6
- 0031036180
- Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
- R.A. Nishimura, J.M. Trusty, D.L. Hayes, D.M. Ilstrup, D.R. Larson, S.N. Hayes, T.G. Allison, and A.J. Tajik Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial J Am Coll Cardiol 29 1997 435 441
- (1997) J Am Coll Cardiol , vol.29 , pp. 435-441
- Nishimura, R.A.¹ Trusty, J.M.² Hayes, D.L.³ Ilstrup, D.M.⁴ Larson, D.R.⁵ Hayes, S.N.⁶ Allison, T.G.⁷ Tajik, A.J.⁸

7
- 0030580929
- A U.S. Experiment on young children ignites painful debate
- 12 June 1996, pp. 1, A10
- M. Moss A U.S. experiment on young children ignites painful debate Wall Street J 12 1996 1 12 June 1996, pp. 1, A10
- (1996) Wall Street J , vol.12 , pp. 1
- Moss, M.¹

8
- 0029043605
- Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
- U. Sigwart Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Lancet 346 1995 211 214
- (1995) Lancet , vol.346 , pp. 211-214
- Sigwart, U.¹

9
- 84872551624
- Hypertrophic cardiomyopathy
- B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
- (2013) Lancet , vol.381 , pp. 242-255
- Maron, B.J.¹ Maron, M.S.²

10
- 0035923562
- Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy
- I. Olivotto, F. Cecchi, S.A. Casey, A. Dolara, J.H. Traverse, and B.J. Maron Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2001 2517 2524
- (2001) Circulation , vol.104 , pp. 2517-2524
- Olivotto, I.¹ Cecchi, F.² Casey, S.A.³ Dolara, A.⁴ Traverse, J.H.⁵ Maron, B.J.⁶

11
- 13844253872
- Permanent pacing is a risk factor for the development of heart failure
- Myocardial Infarction Data Acquisition System Study Group (MIDAS 9)
- R.S. Freudenberger, A.C. Wilson, J. Lawrence-Nelson, J.M. Hare, J.B. Kostis Myocardial Infarction Data Acquisition System Study Group (MIDAS 9) Permanent pacing is a risk factor for the development of heart failure Am J Cardiol 95 2005 671 674
- (2005) Am J Cardiol , vol.95 , pp. 671-674
- Freudenberger, R.S.¹ Wilson, A.C.² Lawrence-Nelson, J.³ Hare, J.M.⁴ Kostis, J.B.⁵

12
- 0038311033
- Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction
- MOde Selection Trial Investigators
- M.O. Sweeney, A.S. Hellkamp, K.A. Ellenbogen, A.J. Greenspon, R.A. Freedman, K.L. Lee, G.A. Lamas MOde Selection Trial Investigators Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction Circulation 107 2003 2932 2937
- (2003) Circulation , vol.107 , pp. 2932-2937
- Sweeney, M.O.¹ Hellkamp, A.S.² Ellenbogen, K.A.³ Greenspon, A.J.⁴ Freedman, R.A.⁵ Lee, K.L.⁶ Lamas, G.A.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.